Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Javaheri

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
Circulation|May 2, 2024
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial HypertensionHaiyang Tang, Akash Gupta, Seth A Morrisroe, et al.
Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.
JAMA|April 11, 2023
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical TrialsWesley H Self, Matthew S Shotwell, Kevin W Gibbs, et al.
JAMA Network Open|December 3, 2024
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical TrialSean P Collins, Matthew S Shotwell, Jeffrey R Strich, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
Circulation|May 2, 2024
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial HypertensionHaiyang Tang, Akash Gupta, Seth A Morrisroe, et al.
Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.
JAMA|April 11, 2023
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical TrialsWesley H Self, Matthew S Shotwell, Kevin W Gibbs, et al.
JAMA Network Open|December 3, 2024
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical TrialSean P Collins, Matthew S Shotwell, Jeffrey R Strich, et al.
Pageof 11